Coronavirus peak expected late February: medical advisor - Global Times


The Global Times reports that the number of patients infected with the novel coronavirus pneumonia (COVID-19) will likely peak during the second half of February in southern China, while nationwide, the expected high-point should occur in April, said Zhong Nanshan, the central government's top medical advisor. 

Key notes

  • While new infections are reported daily outside of Central China's Hubei Province, where the outbreak's epicenter Wuhan is located, dropped for 13 consecutive days on Sunday.
  • A statistics model suggested that by the end of February, nationwide infections will have reached 170,000 while actual data as of Monday indicates roughly 70,000, Zhong said on Monday. 
  • "It does not necessarily mean that it will fall immediately after reaching the peak. Reaching the peak refers to accumulated cases or new cases," the expert said, noting the number should peak in late February.
  • Also, the peak does not suggest an inflection.
  • When asked about the massive labor migration following the Spring Festival holidays, and if there would be another peak, Zhong said, "I think probably not," noting that authorities have adopted strict inspection and quarantine measures, making another outbreak unlikely. 
  • Zhong emphasized that Wuhan has a very high morbidity rate. Confirmed COVID-19 patients in the provincial capital make up 80 percent of the nationwide total, and 95 percent of the nationwide fatality rate.  
  • Zhong noted that if the problem in Wuhan is solved by separating healthy people from patients and dealing with a significant number of suspected patients, it would have a positive influence nationwide. 
  • Treating COVID-19 patients is more challenging than treating SARS patients as critically ill patients who do not receive timely treatment will suffer continuous damage.  "But it does not mean there is no hope at all," Zhong said, noting that research teams have been working to find more effective antiviral drugs, including new progress with Traditional Chinese Medicine and exploring new treatment methods. 

Market implications

 

 

Share: Feed news

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.

Recommended content


Recommended content

Editors’ Picks

AUD/USD posts modest gains above 0.6600 amid weak UoM Consumer Sentiment data

AUD/USD posts modest gains above 0.6600 amid weak UoM Consumer Sentiment data

The AUD/USD pair snaps the two-day losing streak near 0.6615 amid the consolidation of the US Dollar in Monday’s early Asian session. Meanwhile, the US Dollar Index hovers around near 105.50 after retracing from its highest level since early May near 105.80.

AUD/USD News

EUR/USD: Central banks’ decisions will keep taking their toll

EUR/USD: Central banks’ decisions will keep taking their toll

The EUR/USD pair slid below the 1.0700 mark for the first time in over a month on Friday, as the US Dollar surged on the back of risk aversion. The dismal mood prevailed throughout the week, with a short-lived exception on Wednesday when softer-than-anticipated United States inflation brought a breath of fresh air.

EUR/USD News

Gold gains ground as traders dial up Fed rate cut bets for September

Gold gains ground as traders dial up Fed rate cut bets for September

Gold registered limited gains this week, supported by safe-haven flows and soft inflation data from the US. In the absence of high-impact macroeconomic data releases ahead, investors will pay close attention to technical developments in XAU/USD and comments from Federal Reserve officials. 

Gold News

Bitcoin active addresses hit lowest level in five years, BTC ranges below $67,000

Bitcoin active addresses hit lowest level in five years, BTC ranges below $67,000

Bitcoin, the largest asset by market capitalization, has noted a decline in its active address count per data from Glassnode. A decline in active addresses is typical at a time during a surge in Bitcoin transaction fees.

Read more

Week ahead: RBA, SNB and BoE next to decide, CPI and PMI data also on tap

Week ahead: RBA, SNB and BoE next to decide, CPI and PMI data also on tap

It will be another central-bank-heavy week with the RBA, SNB and BoE. Retail sales will be the highlight in the United States. Plenty of other data also on the way, including flash PMIs and UK CPI.

Read more

Forex MAJORS

Cryptocurrencies

Signatures